Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;5(4):265-9.
doi: 10.4103/0975-7406.120073.

Antibacterial activity of resin rich plant extracts

Affiliations

Antibacterial activity of resin rich plant extracts

Mohd Shuaib et al. J Pharm Bioallied Sci. 2013 Oct.

Abstract

Background: The in vitro antibacterial activity of resin rich methanolic extracts (RRMEs) of Commiphora myrrha, Operculina turpethum, and Pinus roxburghii.

Materials and methods: Different concentration were studied by agar-well diffusion method against Gram-positive (Staphylococcus aureus, Bacillus subtilis, Micrococcus luteus, Enterococcus faecalis) and Gram-negative bacterial strains (Escherichia coli, Pseudomonas aeruginosa, Salmonella typhi, Shigella dysenteriae).

Results: Among all the bacterial strains tested, E. faecalis was most sensitive and S. typhi was resistant to C. myrrha and P. roxburghii. The extracts of O. turpethum were active against all tested strains in which B. subtilis and S. aureus were the most sensitive.

Conclusion: This suggested that the antibacterial activity of RRMEs of O. turpethum was more than C. myrrha and P. roxburghii. This probably explains the potential of these plants against a number of infections caused by bacterial strains tested.

Keywords: Antibacterial drugs; Commiphora myrrha; Operculina turpethum; Pinus roxburghii; glycosidic resins; oleo-gum-resins; oleo-resins.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Zones of inhibition produced by resin rich methanolic extracts of Commiphora myrrha at the tested concentrations (Bl = control; S = standard; A = 1000 μg/ml; B = 500 μg/ml; C = 250 μg/ml; 100 μg/ml)
Figure 2
Figure 2
Zones of inhibition produced by resin rich methanolic extracts of Operculina turpethum at the tested concentrations (Bl = control; S = standard; A = 1000 μg/ml; B = 500 μg/ml; C = 250 μg/ml; 100 μg/ml)
Figure 3
Figure 3
Zones of inhibition produced by resin rich methanolic extracts of Pinus roxburghii at the tested concentrations (Bl = control; S = standard; A = 1000 μg/ml; B = 500 μg/ml; C = 250 μg/ml; 100 μg/ml)

References

    1. Borris RP. Natural products research: Perspectives from a major pharmaceutical company. J Ethnopharmacol. 1996;51:29–38. - PubMed
    1. National Center for Infectious Diseases (NCID) Campaign to prevent antimicrobial resistance in healthcare settings. Centre for Disease Control and Prevention. [Updated 2006 Aug 12]. Available from: http://www.cdc.gov/drugresistance/healthcare/problem.htm .
    1. Chopra I, Hodgson J, Metcalf B, Poste G. New approaches to the control of infections caused by antibiotic-resistant bacteria. An industry perspective. JAMA. 1996;275:401–3. - PubMed
    1. Baquero F. Gram-positive resistance: Challenge for the development of new antibiotics. J Antimicrob Chemother. 1997;39(Suppl A):1–6. - PubMed
    1. Kumar VP, Chauhan NS, Padh H, Rajani M. Search for antibacterial and antifungal agents from selected Indian medicinal plants. J Ethnopharmacol. 2006;107:182–8. - PubMed

LinkOut - more resources